Page 12 - HFA_Dateline_2014_Q2_Summer
P. 12
1980s
In 1982, CDC reports the irst 1982
cases of HIV/AIDS among CDC reports irst AIDS cases
people with hemophilia. By among people with hemophilia.
mid-1983, researchers are
able to isolate the virus that
causes HIV/AIDS. Manu-
facturers of plasma derived January 4, 1983
clotting factor concentrates, CDC hosts a meeting to
attempt to kill these viruses address the growing con-
with dry heat, solvent deter- cern over the safety of
gent treatment, and pasteuri- the nation’s blood supply.
zation with varying degrees No changes were made.
of success. Manufacturers
license and begin develop- 1983
ing heat-treated products, Manufacturers begin issuing factor recalls.
but these are not widely
available due to high cost,
perceived risk, and eficacy. 1980 to 1983 1984
Many in the hemophilia com-
munity become isolated due 1983
to discrimination and fear of The National Hemophilia Foundation sends notices to
being identiied as HIV/AIDS individuals and
positive. Children, most nota- local chapters
bly Ryan White and the Ray urging patients
brothers, are denied entry to continue use
to school. By the late 1980s, of clotting factor,
over 50% of the hemophilia despite warnings
community has been infected from the CDC that the blood supply is tainted with
with HIV/AIDS and/or Hepa- HIV/AIDS.
titis C. In those with severe
hemophilia, the infection rate 1983 and 1984 1984
is over 90%. The decades- Several manufacturers The irst diagnostic
old concern over hepatitis is begin the development test for the retrovirus that
now far overshadowed by the of heat treated factor causes HIV is developed.
HIV/AIDS epidemic. concentrate after testing The number of people
shows the process kills with hemophilia being
both HIV and some diagnosed with HIV/AIDS
hepatitis viruses. is growing rapidly.
12 Dateline Federation | Summer 2014
In 1982, CDC reports the irst 1982
cases of HIV/AIDS among CDC reports irst AIDS cases
people with hemophilia. By among people with hemophilia.
mid-1983, researchers are
able to isolate the virus that
causes HIV/AIDS. Manu-
facturers of plasma derived January 4, 1983
clotting factor concentrates, CDC hosts a meeting to
attempt to kill these viruses address the growing con-
with dry heat, solvent deter- cern over the safety of
gent treatment, and pasteuri- the nation’s blood supply.
zation with varying degrees No changes were made.
of success. Manufacturers
license and begin develop- 1983
ing heat-treated products, Manufacturers begin issuing factor recalls.
but these are not widely
available due to high cost,
perceived risk, and eficacy. 1980 to 1983 1984
Many in the hemophilia com-
munity become isolated due 1983
to discrimination and fear of The National Hemophilia Foundation sends notices to
being identiied as HIV/AIDS individuals and
positive. Children, most nota- local chapters
bly Ryan White and the Ray urging patients
brothers, are denied entry to continue use
to school. By the late 1980s, of clotting factor,
over 50% of the hemophilia despite warnings
community has been infected from the CDC that the blood supply is tainted with
with HIV/AIDS and/or Hepa- HIV/AIDS.
titis C. In those with severe
hemophilia, the infection rate 1983 and 1984 1984
is over 90%. The decades- Several manufacturers The irst diagnostic
old concern over hepatitis is begin the development test for the retrovirus that
now far overshadowed by the of heat treated factor causes HIV is developed.
HIV/AIDS epidemic. concentrate after testing The number of people
shows the process kills with hemophilia being
both HIV and some diagnosed with HIV/AIDS
hepatitis viruses. is growing rapidly.
12 Dateline Federation | Summer 2014
